Camovis

Executive Summary

Camovis is a German digital health and medical device services company that provides flexible, on-demand clinical study support through a network of over 350 qualified research professionals. The company's core offering, 'Flying Research Professionals,' delivers mobile, tailored personnel solutions to sponsors, CROs, and study sites across Germany, Austria, and Switzerland, enhancing the quality, efficiency, and success of clinical trials across all phases (I-IV), non-interventional studies, and digital health application (DiGA/DiPA) projects. Founded in 2018 and headquartered in Munich, Camovis addresses a critical bottleneck in clinical research—the shortage of skilled personnel—by offering a scalable, on-demand workforce that adapts to fluctuating trial demands. As the clinical trial landscape increasingly shifts toward decentralized and flexible models, Camovis is well-positioned to capitalize on growing demand for specialized, mobile clinical research support. While the company operates in a competitive market, its niche focus, regional expertise, and proven network provide a solid foundation for growth. With no disclosed financials or funding details, the company appears to be privately held and potentially bootstrapped, but its service-based model offers recurring revenue potential. The regulatory push for digital health solutions in Germany (DiGA/DiPA) further supports demand for clinical validation services, positioning Camovis for steady expansion.

Upcoming Catalysts (preview)

• Q3 2026Expansion of DiGA/DiPA Market in Germany70% success
• Q4 2026Strategic Partnership with Major Pharmaceutical Company50% success
• Q2 2027Launch of Decentralized Clinical Trial Support Service40% success